Skip to main content

Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.

Publication ,  Journal Article
Pulvirenti, A; Margonis, GA; Morales-Oyarvide, V; McIntyre, CA; Lawrence, SA; Goldman, DA; Gonen, M; Weiss, MJ; Ferrone, CR; He, J; Brennan, MF ...
Published in: Ann Surg
December 1, 2021

OBJECTIVE: To evaluate the influence of consensus guidelines on the management of intraductal papillary mucinous neoplasms (IPMN) and the subsequent changes in pathologic outcomes. BACKGROUND: Over time, multiple guidelines have been developed to identify high-risk IPMN. We hypothesized that the development and implementation of guidelines should have increased the percentage of resected IPMN with high-risk disease. METHODS: Memorial Sloan-Kettering (MSK), Johns Hopkins (JH), and Massachusetts General Hospital (MGH) databases were queried for resected IPMN (2000-2015). Patients were categorized into main-duct (MD-IPMN) versus branch-duct (BD-IPMN). Guideline-specific radiographic/endoscopic features were recorded. High-risk disease was defined as high-grade dysplasia/carcinoma. Fisher's exact test was used to detect differences between institutions. Logistic regression evaluated differences between time-points [preguidelines (pre-GL, before 2006), Sendai (SCG, 2006-2012), Fukuoka (FCG, after 2012)]. RESULTS: The study included 1210 patients. The percentage of BD-IPMN with ≥1 high-risk radiographic feature differed between centers (MSK 69%, JH 60%, MGH 45%; P < 0.001). In MD-IPMN cohort, the presence of radiographic features such as solid component and main pancreatic duct diameter ≥10 mm also differed (solid component: MSK 38%, JH 30%, MGH 18%; P < 0.001; duct ≥10 mm: MSK 49%, JH 32%, MGH 44%; P < 0.001). The percentage of high-risk disease on pathology, however, was similar between institutions (BD-IPMN: P = 0.36, MD-IPMN: P = 0.48). During the study period, the percentage of BD-IPMN resected with ≥1 high-risk feature increased (52% pre-GL vs 67% FCG; P = 0.005), whereas the percentage of high-risk disease decreased (pre-GL vs FCG: 30% vs 20%). For MD-IPMN, there was not a clear trend towards guideline adherence, and the rate of high-risk disease was similar over the time (pre-GL vs FCG: 69% vs 67%; P = 0.63). CONCLUSION: Surgical management of IPMN based on radiographic criteria is variable between institutions, with similar percentages of high-risk disease. Over the 15-year study period, the rate of BD-IPMN resected with high-risk radiographic features increased; however, the rate of high-risk disease decreased. Better predictors are needed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

December 1, 2021

Volume

274

Issue

6

Start / End Page

e980 / e987

Location

United States

Related Subject Headings

  • Surgery
  • Practice Guidelines as Topic
  • Pancreatic Neoplasms
  • Neoplasm Staging
  • Neoplasm Grading
  • Middle Aged
  • Male
  • Humans
  • Female
  • Carcinoma, Pancreatic Ductal
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pulvirenti, A., Margonis, G. A., Morales-Oyarvide, V., McIntyre, C. A., Lawrence, S. A., Goldman, D. A., … Allen, P. J. (2021). Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study. Ann Surg, 274(6), e980–e987. https://doi.org/10.1097/SLA.0000000000003703
Pulvirenti, Alessandra, Georgios A. Margonis, Vicente Morales-Oyarvide, Caitlin A. McIntyre, Sharon A. Lawrence, Debra A. Goldman, Mithat Gonen, et al. “Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.Ann Surg 274, no. 6 (December 1, 2021): e980–87. https://doi.org/10.1097/SLA.0000000000003703.
Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, et al. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study. Ann Surg. 2021 Dec 1;274(6):e980–7.
Pulvirenti, Alessandra, et al. “Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.Ann Surg, vol. 274, no. 6, Dec. 2021, pp. e980–87. Pubmed, doi:10.1097/SLA.0000000000003703.
Pulvirenti A, Margonis GA, Morales-Oyarvide V, McIntyre CA, Lawrence SA, Goldman DA, Gonen M, Weiss MJ, Ferrone CR, He J, Brennan MF, Cameron JL, Lillemoe KD, Kingham TP, Balachandran V, Qadan M, D’Angelica MI, Jarnagin WR, Wolfgang CL, Castillo CF-D, Allen PJ. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study. Ann Surg. 2021 Dec 1;274(6):e980–e987.

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

December 1, 2021

Volume

274

Issue

6

Start / End Page

e980 / e987

Location

United States

Related Subject Headings

  • Surgery
  • Practice Guidelines as Topic
  • Pancreatic Neoplasms
  • Neoplasm Staging
  • Neoplasm Grading
  • Middle Aged
  • Male
  • Humans
  • Female
  • Carcinoma, Pancreatic Ductal